Patrick Rudolf Aghanian
Corporate Officer/Principal bij DR. REDDY'S LABORATORIES LIMITED
Profiel
Patrick Rudolf Aghanian is currently the Chief Executive Officer-European Generics at Dr. Reddy's Laboratories Ltd.
He previously worked as a Non-Executive Director at Hoechst Pakistan Ltd.
from 2015 to 2017.
He also served as a Member-Supervisory Board at Zentiva International as.
Aghanian received his undergraduate degree from the University of California, Los Angeles and his MBA from UCLA Anderson School of Management.
Actieve functies van Patrick Rudolf Aghanian
Bedrijven | Functie | Begin |
---|---|---|
DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 07-10-2019 |
Eerdere bekende functies van Patrick Rudolf Aghanian
Bedrijven | Functie | Einde |
---|---|---|
HOECHST PAKISTAN LIMITED | Director/Board Member | 25-04-2017 |
Zentiva International as
Zentiva International as Pharmaceuticals: MajorHealth Technology Zentiva International as develops and manufactures pharmaceutical preparations. Its products include medicine for the treatment of cardiovascular, respiratory, dermatology and gastrointestinal diseases, blood disorders, and inflammations. The company was founded on April 2, 1996 and is headquartered in Bratislava, Slovakia. | Director/Board Member | - |
Opleiding van Patrick Rudolf Aghanian
University of California, Los Angeles | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DR. REDDY'S LABORATORIES LIMITED | Health Technology |
HOECHST PAKISTAN LIMITED | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Zentiva International as
Zentiva International as Pharmaceuticals: MajorHealth Technology Zentiva International as develops and manufactures pharmaceutical preparations. Its products include medicine for the treatment of cardiovascular, respiratory, dermatology and gastrointestinal diseases, blood disorders, and inflammations. The company was founded on April 2, 1996 and is headquartered in Bratislava, Slovakia. | Health Technology |